ML141 was recently used as a potent Cdc42 inhibitor in cancer stem cells to downregulate epidermal growth factor receptor (EGFR) and redox/Fyn/c-Cbl signaling pathways [75, 76], and to regulate apoptosis in neuroblastoma cells [77]. This evidence concerns the gene CDC42 and neuroblastoma.